CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Vnitř. Lék., 47, 2001, No. 2, p. 92-98
 
High-dosage Chemotherapy with Support of Autologous Haematopoietic Cells in the Treatment of Multiple Myeloma - Review of Contemporary Possibilities 
Ráčil Z., Adam Z., Hájek R.,Tomíška M., Krejčí M., Křivanová A., Höklová J., Doubek M., Mayer J., Vorlíček J. 

Interní hematoonkologická klinika FN Brno, pracoviště Bohunice, přednosta prof. MUDr. J. Vorlíček, CSc.
 


Summary:

       High-dosage chemotherapy with autologous transplantation of haematopietic stem cells prolonged the survival of patients with multiple myeloma as compared with results of standard chemotherapy, on average by 1.5 years. Nowadays this method is the standard treatment for suitable patients. Findings assembled recently are discussed by the authors.

        Key words: Multiple myeloma - High-dosage chemotherapy - Autologous transplantation of hae- matopoietic cells
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER